Secretary of Health Robert F. Kennedy Jr.'s newly constituted Advisory Committee on Immunization Practices (ACIP) is poised to revisit recommendations for COVID-19, hepatitis B, and chickenpox vaccines. This week's meeting in Atlanta will see votes on these crucial immunizations, prompting apprehension among public health experts. The specific details of the voting agenda remain unclear, despite the recent announcement of five new committee members.
This uncertainty underscores the concerns of experts like Dr. William Schaffner of Vanderbilt University, who expressed apprehension about the potential for unwarranted questioning of vaccine safety among parents. A particularly worrisome possibility is a vote that would restrict access to vaccines for low-income families through the Vaccines For Children (VFC) program, a cornerstone of childhood vaccination in the US, currently responsible for roughly half of all childhood immunizations.
The ACIP's recommendations significantly influence the CDC's guidelines, and these recommendations heavily impact the actions of doctors and vaccination programs nationwide. Kennedy's appointment of a panel featuring several individuals with anti-vaccine views has already triggered controversy. The previous ACIP, dismissed by Kennedy earlier this year, had typically reaffirmed recommendations for respiratory vaccines annually. Kennedy's ACIP previously opted to recommend flu shots but remained silent on COVID-19 vaccines. He also drew substantial criticism after removing COVID-19 vaccinations from the CDC's recommendations for healthy children and pregnant women. While the CDC clarified that families could still access the vaccine, the situation has become more complex with the FDA narrowing the use of the newest COVID-19 formulations for healthy younger adults and children. The ACIP's upcoming decisions regarding this season’s COVID-19 vaccine recommendations, and especially their inclusion in the VFC program, will have profound consequences on the accessibility of these crucial vaccines.
The ACIP will also reassess recommendations for hepatitis B and chickenpox vaccinations. While the effectiveness and safety of hepatitis B vaccinations, particularly for newborns, are well-established, the panel's intention to revisit these guidelines is troubling to many. Similarly, although the safety concerns surrounding the MMRV combination shot for chickenpox have been addressed in previous ACIP recommendations, the panel’s revisitation raises concerns about the intent behind these reviews. Experts, like Dr. Sean O’Leary of the American Academy of Pediatrics, fear that these reviews are an attempt to undermine public trust in vaccinations.
The five new committee members announced by HHS include a pharmacist, an obstetrician-gynecologist, a pediatric cardiologist with controversial viewpoints on vaccine-related cardiovascular issues, a transplant specialist, and a disease researcher who has expressed anti-vaccine sentiment. Their inclusion further fuels concerns about the direction of the ACIP under Kennedy’s leadership and the potential impact on public health.
---
Originally published at: https://apnews.com/article/vaccines-cdc-covid-hepatitis-chickenpox-844d270e69b77f8fe2da12eab75ed926
